SMR · NuScale Power Corporation

Current Thesis

NuScale Power’s remaining commercial case is that a binding Tennessee Valley Authority power contract arrives by end-2026 before the shares lose the July reference close of $7.96. That is a separate, low-conviction proposition from the August trading-range recovery, which failed when the market closed at $8.61 on 2026-09-11, below its published $8.64 invalidation level.

The commercial story remains the conversion of ENTRA1 Energy’s framework with the Tennessee Valley Authority (TVA) into a definitive power purchase agreement (PPA). NuScale’s 2025-09-03 announcement described potential deployment of up to 6 gigawatts; the end-2026 signing objective was attributed to management by The Motley Fool on 2026-08-28. The reviewed evidence contains no subsequent definitive agreement. NuScale announcement.

As an inference about the existing market story, the narrative is dead — the 2026-09-11 close broke the August floor, while UBS downgraded the company to Sell from Neutral and reduced its analyst target to $6 from $10 that day. A signed contract would constitute new commercial evidence; the existing framework has not supplied it. Downgrade coverage.

Bullish and bearish views on NuScale Power Corporation

The model's bull view on NuScale Power Corporation (SMR), in brief: The proposed customer program remains substantial. The bear view: Revenue has not confirmed deployment expectations. Both cases follow in full.

Bull Case

• The proposed customer program remains substantial. NuScale’s 2025-09-03 announcement described up to 6 gigawatts of deployment through ENTRA1 and TVA. A definitive PPA signed by 2026-12-31, before a daily close below $7.96, would satisfy the remaining commercial case; another framework announcement would not. Company announcement.
• The last reported liquidity provides context. NuScale’s Q2 results released on 2026-08-05 reported roughly $1.9 billion in cash, cash equivalents and short- and long-term investments at 2026-06-30, alongside a quarterly net loss of $50.1 million. Those are historical balances, not a September liquidity reading.

Bear Case

• Revenue has not confirmed deployment expectations. NuScale reported Q2 revenue of $75,000 on 2026-08-05 against the $8.910 million consensus cited by Benzinga. That quarter does not establish a revenue trend, but it supplies no evidence of commercial scale.
• The latest analyst revision is adverse. UBS’s 2026-09-11 downgrade cited uncertain construction timelines and missing customer commitments while reducing its target to $6. These are UBS’s judgments, not a company schedule or a research price forecast. Downgrade coverage.
• Romanian execution concerns now have documentation. The Prime Minister’s Control Body report published on 2026-09-11 found that Doicești’s second front-end engineering and design phase finished 20 months behind its original schedule. It recorded a December 2025 project-cost estimate of $6.5 billion; Nuclearelectrica attributed delays to approvals, negotiations, financing and execution requirements. These are historical findings, not a newly announced cancellation. Published inspection report.
• Equity issuance remains an unresolved variable. The 2026-08-11 disclosure authorised an at-the-market equity offering of up to $750 million, according to Benzinga. Authorisation does not establish that shares were subsequently issued; the amount used is missing from the evidence reviewed here.

Setup & Price Structure

The adjusted daily series records a 2026-09-11 close of $8.61, below the 2026-08-18 close of $8.64 that defined the published August floor. The 2026-08-25 close of $9.81 remains the former range ceiling. The September close therefore records a failed range, rather than a successful retest.

At 2026-09-11, the shares were 83.9% below their $53.43 trailing 52-week high and down 12.9% over three months. The 14-period relative strength index was 44.6. No moving-average value or slope is supplied, so distance above a rising average cannot be assessed.

The 2026-07-20 close of $7.96 supplies the prospective boundary for the remaining contract-led case. It does not replace or reverse the already-triggered $8.64 condition. A daily close below $7.96 before a definitive TVA PPA ends that remaining case; the 2026-07-17 low of $7.21 is a historical reference, with no forecast of a visit attached.

Attention clustered around leveraged nuclear exchange-traded funds in Benzinga’s 2026-09-08 coverage and an investor-radar article on 2026-09-09. MT Newswires reported more than 70.3 million shares traded by the afternoon of 2026-09-11, against its cited daily average of about 31.8 million. This establishes attention and turnover, not the identity or direction of the marginal investor. MT Newswires report.

An updated count for the 2026-08-31 settlement is missing, although its scheduled publication date was 2026-09-10. Continued covering or renewed short accumulation cannot be established. FINRA reporting calendar.

Catalyst Calendar (next 30 days)

• 2026-09-24 — Short-interest publication. The Financial Industry Regulatory Authority (FINRA) schedules publication for the 2026-09-15 settlement on this date. The observation covers positioning after the 2026-09-11 downgrade; it does not resolve the contract thesis. FINRA calendar.
• 2026-10-09 — Short-interest publication. FINRA schedules the 2026-09-30 settlement report for this date, providing a later comparison after the downgrade and Romanian report. FINRA calendar.

The previously estimated 2026-09-15 Nuclearelectrica half-year reporting event is removed: its official investor-relations archive dates the presentation to 2026-08-14. No confirmed NuScale commercial signing date was identified inside the next 30 days. Nuclearelectrica results archive.

• 2026-12-31 — Reported management signing horizon. This marks the end-2026 definitive TVA PPA objective attributed to management by The Motley Fool on 2026-08-28, not a scheduled signing ceremony. A binding agreement by this deadline is the event on which the remaining commercial thesis turns.

What Would Change Our Mind

Loss of the July reference close would end the remaining contract-led case: a daily close below $7.96 before a definitive TVA PPA constitutes invalidation. The deadline supplies an independent failure condition if 2026-12-31 passes without that agreement. The earlier August-range thesis already failed at the 2026-09-11 close of $8.61.

A publicly disclosed definitive ENTRA1–TVA PPA by 2026-12-31, preceding the price breach, would establish the specified commercial outcome. Its disclosed payment obligations and implementation schedule would then determine the economic interpretation. A recovery above the 2026-08-25 closing ceiling of $9.81 would establish a price recovery only; it would not establish a contract.

Correlation Notes

Benzinga’s 2026-09-08 coverage grouped NuScale and Oklo with leveraged nuclear funds, while the 2026-09-11 downgrade coverage reported both equities lower during the morning. Those observations document shared attention but are too few to establish a stable correlation or attribute NuScale’s decline to sector flows. September 11 coverage.

This is a single-name commercial case. The 2025-09-03 TVA program announcement concerns NuScale technology through ENTRA1; a broader nuclear rally cannot satisfy the specified requirement for a definitive PPA.